Featured
Health Topics
Any Category-
See more
- Bacterial Infections and Mycoses 35
- Cardiovascular Diseases 45
- Chemically-Induced Disorders 28
- Congenital, Hereditary, and Neonatal Diseases and Abnormalities 54
- Digestive System Diseases 37
- Endocrine System Diseases 46
- Eye Diseases 7
- Female Urogenital Diseases and Pregnancy Complications 36
- Hemic and Lymphatic Diseases 38
- Immune System Diseases 61
- Male Urogenital Diseases 34
- Musculoskeletal Diseases 15
- Neoplasms 83
- Nervous System Diseases 69
- Nutritional and Metabolic Diseases 80
- Otorhinolaryngologic Diseases 11
- Parasitic Diseases 10
- Pathological Conditions, Signs and Symptoms 150
- Respiratory Tract Diseases 19
- Skin and Connective Tissue Diseases 18
- Stomatognathic Diseases 8
- Virus Diseases 40
- Wounds and Injuries 8
Search Clinical Trials
Completed
Chronic Hypertension and Pregnancy (CHAP) Project (External Link)
During pregnancy, chronic hypertension (CHTN) is the most common major medical disorder encountered, occurring in 2-6%. The substantial negative effect of CHTN on pregnancy includes a consistent 3- to 5-fold …
Baylor Role:
Collaborator
Completed
Fast-Fail Trials in Mood and Anxiety Spectrum Disorders; Kappa Opioid Receptor Phase 2a (External Link)
FAST-MAS addresses an important problem and critical barrier to progress in Mood and Anxiety Spectrum Disorders and if the aims of the project are achieved, FAST-MAS could shift scientific knowledge, …
Baylor Role:
Collaborator
Completed
Home Away From Home - Medical Outcomes (External Link)
This is a bidirectional observational cohort study. Participants will be patients less that 19 years of age at diagnosis receiving or having received chemotherapy for AML from seventeen participating pediatric …
Baylor Role:
Collaborator
Completed
Rapid Infusion Rituximab, Hematologic, Oncologic, and Rheumatologic Disorders (External Link)
The standard of care in patients receiving rituximab is to give the dose slowly and gradually increase the rate of rituximab until the full dose is given, which may take …
Baylor Role:
Lead Sponsor
Completed
Genomic Sequencing for Childhood Risk and Newborn Illness (External Link)
The objective of this research protocol is to conduct a randomized clinical trial to assess the benefits and risks of adding the information from a genomic sequencing report to physician-mediated …
Baylor Role:
Collaborator
Completed
Saving Lives at Birth: Primary Prevention of Periodontal Disease in Relation to Preterm Birth in Malawi (External Link)
Significance and Impact: Adverse birth outcomes related to the length of gestation (preterm birth) are recognized as one of the most significant disorders in maternal-child health at a global scale. …
Baylor Role:
Lead Sponsor
Completed
Evaluation the Treatment of Tamoxifen of Low/Intermediate Risk Bladder Tumors (External Link)
Patients with primary or recurrent low/intermediate-risk papillary urothelial carcinoma of the bladder will undergo resection of all but one marker lesion, measuring at least 6mm but no greater than 10mm, …
Baylor Role:
Lead Sponsor
Completed
TAA-Specific CTLS for Solid Tumors (TACTASOM) (External Link)
Blood will be collected from the patient and TAA-specific CTLs will be made. The cells will be injected by IV into the patient over 1 - 10 minutes. The patient …
Baylor Role:
Lead Sponsor
Completed
Using a Tailored Health Information Technology Driven Intervention to Improve Health Literacy and Medication Adherence (External Link)
Physicians seeing patients in the outpatient clinics will write patient's statin and/or antiplatelet prescription and the patient's cell phone numbers on an Optical Mark Recognition (OMR) sheet. The sheet will …
Baylor Role:
Collaborator
Completed
Assessment of Worldwide Acute Kidney Injury Epidemiology in Neonates (External Link)
The investigators will conduct a multi-center retrospective cohort study. The investigators will enroll eligible infants who meet inclusion and exclusion criteria at each center for 3 consecutive months. Based on …
Baylor Role:
Collaborator